letter 2025 Comment on “Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients” ·doi:10.1016/j.jfma.2025.08.034
review 2025 Regarding “Changes in Sexual Function After Minimally Invasive Hysterectomy in Reproductive-Aged Women: A Systematic Review and Meta-Analysis” ·doi:10.1016/j.jmig.2025.08.020